Revisiting the role of TEG-PM in stroke prevention by drug selection for mono-antiplatelet medication following dual-antiplatelet treatment.

Lei YanWenzhao LiangBingyang ZhaoZhongyu ZhaoKai ZhangLingling WangJing Mang

Published in: Neuro endocrinology letters (2024)

The TEG-PM could be a tangible preprocessing in drug selection for MAPT following DAPT in patients with minor strokes or TIAs, especially for those with non-stented ICASs.

Keyphrases

particulate matter
air pollution
adverse drug
polycyclic aromatic hydrocarbons
heavy metals
atrial fibrillation
healthcare
water soluble
antiplatelet therapy
emergency department
drug induced
risk assessment
combination therapy
electronic health record